Assessing the role of ADAM10 in Trastuzumab treatment and resistance
<p>Overexpression of the HER2 receptor occurs in about 15-20% of all breast cancers and is correlated with poor prognosis. Trastuzumab (Herceptin®), a monoclonal antibody targeting HER2, was shown to prolong survival of these patients. However, primary or acquired resistance remains a drawback...
1. autor: | Feldinger, K |
---|---|
Kolejni autorzy: | Kong, A |
Format: | Praca dyplomowa |
Język: | English |
Wydane: |
2012
|
Hasła przedmiotowe: |
Podobne zapisy
-
Functional organisation of the Hrd1 ubiquitin ligase complex and its role in ERAD
od: Schulz, J
Wydane: (2013) -
The role and regulation of Asterless in the centrosome cycle
od: Novak, ZA
Wydane: (2014) -
Characterisation of AEBP2: a polycomb repressive complex 2 component
od: Grijzenhout, A
Wydane: (2013) -
Cell stress response and hypoxia in breast cancer
od: Milani, M, i wsp.
Wydane: (2011) -
Nitric oxide: a chemical effector of pathogenesis in magnaporthe oryzae
od: Johnson, J
Wydane: (2011)